1.
de Portu S, Mantovani LG, Olivieri I. Cost-utility analysis of abatacept in rheumatoid arthritis in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 2008;9(1):19-26. https://doi.org/10.7175/fe.v9i1.212